Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale L Greiner

Showing results (81-90 of 203) with videos related to

Pageof 21
Sort By:
Plos One|October 23, 2013
Salicylate prevents virus-induced type 1 diabetes in the BBDR ratChaoxing Yang, Agata Jurczyk, Philip diIorio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2015
The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid MiceMaximiliano Presa, Yi-Guang Chen, Alexandra E Grier, et al.
Diabetes|January 24, 2003
NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance inductionTodd Pearson, Thomas G Markees, Linda S Wicker, et al.
Xenotransplantation|June 8, 2006
Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in miceHideyuki Masaki, Michael C Appel, Linda Leahy, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 26, 2022
Analysis of Salmonella Typhi Pathogenesis in a Humanized Mouse ModelTaylor A Stepien, Stephen J Libby, Joyce E Karlinsey, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2004
Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) miceScott J Banuelos, Leonard D Shultz, Dale L Greiner, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 31, 2013
Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγ(null) mice treated with alogliptinAgata Jurczyk, Philip Diiorio, Dean Brostowin, et al.
Diabetes|November 14, 2014
Viral infection of engrafted human islets leads to diabetesGlen R Gallagher, Michael A Brehm, Robert W Finberg, et al.
Immunology|April 29, 2016
Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host diseaseRiyasat Ali, Jeffrey Babad, Antonia Follenzi, et al.
Transplantation|October 15, 2003
NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftmentLeonard D Shultz, Scott Banuelos, Bonnie Lyons, et al.
Pageof 21

Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
Plos One|October 23, 2013
Salicylate prevents virus-induced type 1 diabetes in the BBDR ratChaoxing Yang, Agata Jurczyk, Philip diIorio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 19, 2015
The Presence and Preferential Activation of Regulatory T Cells Diminish Adoptive Transfer of Autoimmune Diabetes by Polyclonal Nonobese Diabetic (NOD) T Cell Effectors into NSG versus NOD-scid MiceMaximiliano Presa, Yi-Guang Chen, Alexandra E Grier, et al.
Diabetes|January 24, 2003
NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance inductionTodd Pearson, Thomas G Markees, Linda S Wicker, et al.
Xenotransplantation|June 8, 2006
Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in miceHideyuki Masaki, Michael C Appel, Linda Leahy, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 26, 2022
Analysis of Salmonella Typhi Pathogenesis in a Humanized Mouse ModelTaylor A Stepien, Stephen J Libby, Joyce E Karlinsey, et al.
Clinical Immunology (Orlando, Fla.)|August 17, 2004
Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) miceScott J Banuelos, Leonard D Shultz, Dale L Greiner, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|December 31, 2013
Improved function and proliferation of adult human beta cells engrafted in diabetic immunodeficient NOD-scid IL2rγ(null) mice treated with alogliptinAgata Jurczyk, Philip Diiorio, Dean Brostowin, et al.
Diabetes|November 14, 2014
Viral infection of engrafted human islets leads to diabetesGlen R Gallagher, Michael A Brehm, Robert W Finberg, et al.
Immunology|April 29, 2016
Genetically modified human CD4(+) T cells can be evaluated in vivo without lethal graft-versus-host diseaseRiyasat Ali, Jeffrey Babad, Antonia Follenzi, et al.
Transplantation|October 15, 2003
NOD/LtSz-Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftmentLeonard D Shultz, Scott Banuelos, Bonnie Lyons, et al.
Pageof 21